HEADER MEMBRANE PROTEIN 05-MAY-20 6WVA TITLE TAKIFUGU RUBRIPES VKOR-LIKE WITH VITAMIN K1 EPOXIDE AT NON-CATALYTIC TITLE 2 STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VITAMIN K EPOXIDE REDUCTASE-LIKE PROTEIN, TERMINI COMPND 3 RESTRAINED BY GREEN FLUORESCENT PROTEIN; COMPND 4 CHAIN: A; COMPND 5 EC: 1.17.4.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AEQUOREA VICTORIA, TAKIFUGU RUBRIPES; SOURCE 3 ORGANISM_COMMON: JELLYFISH, JAPANESE PUFFERFISH, FUGU RUBRIPES; SOURCE 4 ORGANISM_TAXID: 6100, 31033; SOURCE 5 GENE: GFP, VKORC1L1; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS VITAMIN K EPOXIDE REDUCTASE, VKOR, VKOR-LIKE PROTEIN, VKORL, MEMBRANE KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU,N.SUKUMAR,W.LI REVDAT 4 06-NOV-24 6WVA 1 REMARK REVDAT 3 15-NOV-23 6WVA 1 REMARK REVDAT 2 18-OCT-23 6WVA 1 REMARK REVDAT 1 10-MAR-21 6WVA 0 JRNL AUTH S.LIU,S.LI,G.SHEN,N.SUKUMAR,A.M.KREZEL,W.LI JRNL TITL STRUCTURAL BASIS OF ANTAGONIZING THE VITAMIN K CATALYTIC JRNL TITL 2 CYCLE FOR ANTICOAGULATION. JRNL REF SCIENCE V. 371 2021 JRNL REFN ESSN 1095-9203 JRNL PMID 33154105 JRNL DOI 10.1126/SCIENCE.ABC5667 REMARK 2 REMARK 2 RESOLUTION. 3.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.32 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 8404 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 407 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.3200 - 4.8300 0.98 2738 126 0.1987 0.2301 REMARK 3 2 4.8300 - 3.8300 0.97 2633 141 0.2417 0.3156 REMARK 3 3 3.8300 - 3.3500 0.98 2626 140 0.2603 0.3167 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 85.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 95.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WVA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1000248446. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10574 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 1.08000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2B3P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 42% PEG 400, 50 MM AMMONIUM FORMATE, REMARK 280 0.1 M HEPES PH 7.5, LIPIDIC CUBIC PHASE, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 76.70800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.60850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 76.70800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.60850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 310 REMARK 465 ALA A 311 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 GLU A 124 CG CD OE1 OE2 REMARK 470 ASP A 181 CG OD1 OD2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 312 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 136 -62.10 -93.03 REMARK 500 LEU A 211 -0.70 60.72 REMARK 500 SER A 213 -7.31 72.55 REMARK 500 ASN A 217 -7.52 72.06 REMARK 500 ASP A 275 -167.75 -163.09 REMARK 500 REMARK 500 REMARK: NULL DBREF 6WVA A 1 144 UNP P42212 GFP_AEQVI 1 144 DBREF 6WVA A 145 314 UNP Q6TEK8 Q6TEK8_TAKRU 6 175 DBREF 6WVA A 315 407 UNP P42212 GFP_AEQVI 146 238 SEQADV 6WVA ARG A 30 UNP P42212 SER 30 VARIANT SEQADV 6WVA ASN A 39 UNP P42212 TYR 39 VARIANT SEQADV 6WVA LEU A 64 UNP P42212 PHE 64 VARIANT SEQADV 6WVA CRO A 66 UNP P42212 SER 65 CHROMOPHORE SEQADV 6WVA CRO A 66 UNP P42212 TYR 66 CHROMOPHORE SEQADV 6WVA CRO A 66 UNP P42212 GLY 67 CHROMOPHORE SEQADV 6WVA ARG A 80 UNP P42212 GLN 80 VARIANT SEQADV 6WVA SER A 99 UNP P42212 PHE 99 VARIANT SEQADV 6WVA THR A 105 UNP P42212 ASN 105 VARIANT SEQADV 6WVA THR A 322 UNP P42212 MET 153 VARIANT SEQADV 6WVA ALA A 332 UNP P42212 VAL 163 VARIANT SEQADV 6WVA VAL A 340 UNP P42212 ILE 171 VARIANT SEQADV 6WVA VAL A 375 UNP P42212 ALA 206 VARIANT SEQADV 6WVA SER A 408 UNP P42212 EXPRESSION TAG SEQADV 6WVA ASN A 409 UNP P42212 EXPRESSION TAG SEQADV 6WVA SER A 410 UNP P42212 EXPRESSION TAG SEQADV 6WVA LEU A 411 UNP P42212 EXPRESSION TAG SEQADV 6WVA GLU A 412 UNP P42212 EXPRESSION TAG SEQADV 6WVA VAL A 413 UNP P42212 EXPRESSION TAG SEQADV 6WVA LEU A 414 UNP P42212 EXPRESSION TAG SEQADV 6WVA PHE A 415 UNP P42212 EXPRESSION TAG SEQADV 6WVA GLN A 416 UNP P42212 EXPRESSION TAG SEQRES 1 A 414 MET SER LYS GLY GLU GLU LEU PHE THR GLY VAL VAL PRO SEQRES 2 A 414 ILE LEU VAL GLU LEU ASP GLY ASP VAL ASN GLY HIS LYS SEQRES 3 A 414 PHE SER VAL ARG GLY GLU GLY GLU GLY ASP ALA THR ASN SEQRES 4 A 414 GLY LYS LEU THR LEU LYS PHE ILE CYS THR THR GLY LYS SEQRES 5 A 414 LEU PRO VAL PRO TRP PRO THR LEU VAL THR THR LEU CRO SEQRES 6 A 414 VAL GLN CYS PHE SER ARG TYR PRO ASP HIS MET LYS ARG SEQRES 7 A 414 HIS ASP PHE PHE LYS SER ALA MET PRO GLU GLY TYR VAL SEQRES 8 A 414 GLN GLU ARG THR ILE SER PHE LYS ASP ASP GLY THR TYR SEQRES 9 A 414 LYS THR ARG ALA GLU VAL LYS PHE GLU GLY ASP THR LEU SEQRES 10 A 414 VAL ASN ARG ILE GLU LEU LYS GLY ILE ASP PHE LYS GLU SEQRES 11 A 414 ASP GLY ASN ILE LEU GLY HIS LYS LEU GLU TYR ASN LEU SEQRES 12 A 414 ARG VAL SER THR PRO ARG TRP GLU ARG ILE ALA ARG VAL SEQRES 13 A 414 LEU VAL CYS LEU LEU GLY ILE LEU LEU SER LEU TYR ALA SEQRES 14 A 414 PHE HIS VAL GLU ARG GLU HIS ALA ARG ASP PRO SER TYR SEQRES 15 A 414 LYS ALA LEU CYS ASP VAL SER SER SER ILE SER CYS SER SEQRES 16 A 414 LYS VAL PHE GLY SER ARG TRP GLY ARG GLY PHE GLY LEU SEQRES 17 A 414 LEU GLY SER ILE PHE GLY ASN ASP SER ALA LEU ASN GLN SEQRES 18 A 414 PRO ASN SER VAL TYR GLY ILE VAL PHE TYR ALA PHE GLN SEQRES 19 A 414 LEU LEU LEU GLY MET THR VAL SER ALA MET ALA ALA LEU SEQRES 20 A 414 ILE LEU MET THR THR SER ILE MET SER VAL VAL GLY SER SEQRES 21 A 414 LEU TYR LEU GLY TYR ILE LEU TYR PHE VAL LEU LYS ASP SEQRES 22 A 414 LEU CYS VAL ILE CYS VAL THR THR TYR ALA LEU ASN PHE SEQRES 23 A 414 ILE LEU PHE VAL LEU ASN TYR LYS ARG LEU VAL TYR LEU SEQRES 24 A 414 ASN GLU ALA TRP LYS GLN LYS LEU GLN ALA LYS GLN ASP SEQRES 25 A 414 ASN SER HIS ASN VAL TYR ILE THR ALA ASP LYS GLN LYS SEQRES 26 A 414 ASN GLY ILE LYS ALA ASN PHE LYS ILE ARG HIS ASN VAL SEQRES 27 A 414 GLU ASP GLY SER VAL GLN LEU ALA ASP HIS TYR GLN GLN SEQRES 28 A 414 ASN THR PRO ILE GLY ASP GLY PRO VAL LEU LEU PRO ASP SEQRES 29 A 414 ASN HIS TYR LEU SER THR GLN SER VAL LEU SER LYS ASP SEQRES 30 A 414 PRO ASN GLU LYS ARG ASP HIS MET VAL LEU LEU GLU PHE SEQRES 31 A 414 VAL THR ALA ALA GLY ILE THR HIS GLY MET ASP GLU LEU SEQRES 32 A 414 TYR LYS SER ASN SER LEU GLU VAL LEU PHE GLN MODRES 6WVA CRO A 66 SER CHROMOPHORE MODRES 6WVA CRO A 66 TYR CHROMOPHORE MODRES 6WVA CRO A 66 GLY CHROMOPHORE HET CRO A 66 22 HETNAM CRO {2-[(1R,2R)-1-AMINO-2-HYDROXYPROPYL]-4-(4- HETNAM 2 CRO HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1- HETNAM 3 CRO YL}ACETIC ACID HETSYN CRO PEPTIDE DERIVED CHROMOPHORE FORMUL 1 CRO C15 H17 N3 O5 HELIX 1 AA1 SER A 2 LEU A 7 1 6 HELIX 2 AA2 PRO A 56 VAL A 61 5 6 HELIX 3 AA3 VAL A 68 SER A 72 5 5 HELIX 4 AA4 PRO A 75 HIS A 81 5 7 HELIX 5 AA5 ASP A 82 ALA A 87 1 6 HELIX 6 AA6 PRO A 150 HIS A 178 1 29 HELIX 7 AA7 ASP A 181 ASP A 189 1 9 HELIX 8 AA8 SER A 202 ARG A 206 5 5 HELIX 9 AA9 PRO A 224 MET A 241 1 18 HELIX 10 AB1 SER A 244 PHE A 271 1 28 HELIX 11 AB2 CYS A 277 ALA A 304 1 28 HELIX 12 AB3 TRP A 305 LEU A 309 5 5 HELIX 13 AB4 LYS A 325 ASN A 328 5 4 HELIX 14 AB5 SER A 408 VAL A 413 1 6 SHEET 1 AA112 VAL A 11 VAL A 22 0 SHEET 2 AA112 HIS A 25 ASP A 36 -1 O PHE A 27 N GLY A 20 SHEET 3 AA112 LYS A 41 CYS A 48 -1 O LYS A 41 N ASP A 36 SHEET 4 AA112 HIS A 386 ALA A 396 -1 O MET A 387 N PHE A 46 SHEET 5 AA112 HIS A 368 SER A 377 -1 N SER A 371 O THR A 394 SHEET 6 AA112 SER A 316 ASP A 324 -1 N ILE A 321 O HIS A 368 SHEET 7 AA112 GLY A 329 ASN A 339 -1 O LYS A 331 N THR A 322 SHEET 8 AA112 VAL A 345 PRO A 356 -1 O HIS A 350 N PHE A 334 SHEET 9 AA112 TYR A 92 PHE A 100 -1 N VAL A 93 O THR A 355 SHEET 10 AA112 THR A 105 GLU A 115 -1 O VAL A 112 N TYR A 92 SHEET 11 AA112 THR A 118 ILE A 128 -1 O THR A 118 N GLU A 115 SHEET 12 AA112 VAL A 11 VAL A 22 1 N GLU A 17 O ILE A 123 SSBOND 1 CYS A 188 CYS A 196 1555 1555 2.03 SSBOND 2 CYS A 277 CYS A 280 1555 1555 2.03 LINK C LEU A 64 N1 CRO A 66 1555 1555 1.33 LINK C3 CRO A 66 N VAL A 68 1555 1555 1.37 CISPEP 1 MET A 88 PRO A 89 0 2.33 CRYST1 153.416 49.217 84.236 90.00 112.40 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006518 0.000000 0.002687 0.00000 SCALE2 0.000000 0.020318 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012841 0.00000